13F Pro13F Pro

Michelson Medical Research Foundation, Inc.

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1965304
Institutional-grade research for retail investors

Sector Allocation

  • Other62.5%$70.3M
  • Materials13.3%$15.0M
  • Consumer Discretionary7.7%$8.7M
  • Healthcare7.6%$8.5M
  • Communication Services5.8%$6.6M
  • Real Estate3.1%$3.5M

AUM History

13fpro.ai/research/fund/michelson-medical-research-foundation-inc-1965304

Conviction and streaks

Concentrating · top 10 = 74.6%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

Largest positions — Q3 2026

  • AMRZAMRZ
    $15.0M
  • ISHARES
    $11.8M
  • VANGUARD
    $11.2M
  • ISRGISRG
    $8.5M
  • VANGUARD
    $7.6M
  • ISHARES
    $7.4M
  • CNNECNNE
    $7.4M
  • ISHARES
    $6.5M
  • SPDR
    $4.4M
  • MANUMANU
    $4.2M
  • ISHARES
    $3.7M
  • SAFESAFE
    $3.5M
  • VANGUARD
    $3.1M
  • ISHARES
    $3.1M
  • ISHARES
    $3.0M
  • ISHARES
    $3.0M
  • BATRABATRA
    $2.4M
  • OCSLOCSL
    $2.0M
  • ISHARES
    $2.0M
  • SPDR
    $1.5M

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/michelson-medical-research-foundation-inc-1965304

Michelson Medical Research Foundation, Inc. 13F holdings — Q3 2026

$112.5M portfolio (+4.0% QoQ) · 21 holdings · Q3 2026 13F · top 10 are 75% of the stock portfolio

All holdings — Michelson Medical Research Foundation, Inc. (Q3 2026)

21 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
— ISHARES INC - MSCI STH KOR ETFetf/fund$3.7M—
SAFE$SAFESafehold Inc.$3.5M—
— VANGUARD INDEX FDS - MRNGSTR SML CAPetf/fund$3.1M—
— ISHARES INC - MSCI TAIWAN ETFetf/fund$3.1M—
— ISHARES INC - MSCI BRAZIL ETFetf/fund$3.0M—
— ISHARES INC - MSCI MEXICO ETFetf/fund$3.0M—
BATRA$BATRAAtlanta Braves Holdings, Inc.$2.4M—
OCSL$OCSLOaktree Specialty Lending Corp$2.0M—
— ISHARES INC - MSCI JAPAN ETFetf/fund$2.0M—
— SPDR INDEX SHS FDS - SP CHINA ETFetf/fund$1.5M—
MCD$MCDMCDONALDS CORP$1.3MNew

What changed in Q3 2026

Against the previous quarter's 13F: 3 new, 0 added to, 0 trimmed, 3 sold out. Share-count changes; largest moves by dollar size first.

New positions (3)

  • AMRZ$AMRZAmrize Ltd$15.0M

    first bought this quarter

  • ISRG$ISRGINTUITIVE SURGICAL INC$8.5M

    first bought this quarter

  • MCD$MCDMCDONALDS CORP$1.3M

    first bought this quarter

Added to (0)

No positions added to this quarter.

Trimmed (0)

No positions trimmed this quarter.

Sold out (3)

  • BLDR$BLDRBuilders FirstSource, Inc.was $8.7M

    held 1 qtr

  • CME$CMECME GROUP INC.was $8.6M

    held 1 qtr

  • CRGY$CRGYCrescent Energy Cowas $1.5M

    held 10+ qtrs

Holdings by quarter

Every 13F Michelson Medical Research Foundation, Inc. has filed, 15 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Michelson Medical Research Foundation?

Q3 2026 13F filed with the SEC on Nov 16, 2026. Prices are closing prices as of Nov 19, 2026.

Average quality of Michelson Medical Research Foundation's top 20 holdings: 53/100 (our AI quality score, weighted by position size; 6 of the 20 are scored)

Top 10 since filing

-3.4%

Value-weighted move of the 10 largest stock positions

Turnover

17%

Last quarter; 54% over the last 4

Top 10 weight

75%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

17%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 6 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Michelson Medical Research Foundation, Inc. disclosed 21 positions worth $112.5M in its Form 13F-HR for Q3 2026, led by $AMRZ (Amrize Ltd) at 13.3% of the equity portfolio. During the quarter the fund opened 3 new positions and exited 3 — including a new stake in $AMRZ and a full exit from $BLDR. The portfolio is most concentrated in Other (62.5% of disclosed assets). All figures are sourced directly from Michelson Medical Research Foundation, Inc.’s Form 13F-HR filing with the SEC under CIK 1965304.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Michelson Medical Research Foundation, Inc.

13F Pro is an AI hedge fund tracker and stock research platform. For Michelson Medical Research Foundation, Inc. (SEC CIK: 1965304), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Michelson Medical Research Foundation, Inc.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.